These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16445828)

  • 21. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
    Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low versus high cell turnover in diffusely growing non-Hodgkin's lymphomas.
    Spina D; Leoncini L; Del Vecchio MT; Megha T; Minacci C; Poggi SA; Pileri S; Tosi P; Kraft R; Laissue JA
    J Pathol; 1995 Dec; 177(4):335-41. PubMed ID: 8568587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. cFLIP regulation of lymphocyte activation and development.
    Budd RC; Yeh WC; Tschopp J
    Nat Rev Immunol; 2006 Mar; 6(3):196-204. PubMed ID: 16498450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-Flip protein expression in Burkitt's lymphomas is associated with a poor clinical outcome.
    Valnet-Rabier MB; Challier B; Thiebault S; Angonin R; Margueritte G; Mougin C; Kantelip B; Deconinck E; Cahn JY; Fest T
    Br J Haematol; 2005 Mar; 128(6):767-73. PubMed ID: 15755279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features.
    Osoegawa A; Yoshino I; Kometani T; Yamaguchi M; Kameyama T; Yohena T; Maehara Y
    Cancer; 2006 Jul; 107(1):154-61. PubMed ID: 16721818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary thyroid non-Hodgkin's lymphomas: clinicopathological observations on patients living in the island of Crete.
    Kyriakou D; Bizakis J; Papadakis C; Sakellariou D; Tsardi M; Alexandrakis M; Chelidonis E; Eliopoulosi GD
    Haematologia (Budap); 1996; 27(3):129-33. PubMed ID: 14653449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis.
    Geserick P; Drewniok C; Hupe M; Haas TL; Diessenbacher P; Sprick MR; Schön MP; Henkler F; Gollnick H; Walczak H; Leverkus M
    Oncogene; 2008 May; 27(22):3211-20. PubMed ID: 18084329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L).
    Guseva NV; Rokhlin OW; Taghiyev AF; Cohen MB
    Breast Cancer Res Treat; 2008 Feb; 107(3):349-57. PubMed ID: 17453339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas.
    Lee JJ; Kim DH; Lee NY; Sohn SK; Kim JG; Kim HJ; Do YR; Park YH
    Br J Haematol; 2007 May; 137(4):329-36. PubMed ID: 17408400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized phase II study of interleukin-12 in combination with rituximab in previously treated non-Hodgkin's lymphoma patients.
    Ansell SM; Geyer SM; Maurer MJ; Kurtin PJ; Micallef IN; Stella P; Etzell P; Novak AJ; Erlichman C; Witzig TE
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6056-63. PubMed ID: 17062681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
    Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
    Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous cytomorphologic and multiparametric flow cytometric analysis on lymph node samples is faster than and as valid as histopathologic study to diagnose most non-Hodgkin lymphomas.
    Colorado M; Cuadrado MA; Insunza A; Mazorra F; Acinas O; Iriondo A
    Am J Clin Pathol; 2010 Jan; 133(1):83-91. PubMed ID: 20023262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FcgammaRIIa polymorphism and clinical response to rituximab in non-Hodgkin lymphoma patients.
    Paiva M; Marques H; Martins A; Ferreira P; Catarino R; Medeiros R
    Cancer Genet Cytogenet; 2008 May; 183(1):35-40. PubMed ID: 18474295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic difficulties and treatment of non-Hodgkin lymphoma of the orbit.
    Wanyura H; Uliasz M; Kaminski A; Samolczyk-Wanyura D; Smolarz-Wojnowska A
    J Craniomaxillofac Surg; 2007 Jan; 35(1):39-47. PubMed ID: 17267230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting the outcome in non-Hodgkin lymphoma with molecular markers.
    Kwong YL
    Br J Haematol; 2007 May; 137(4):273-87. PubMed ID: 17408399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rituximab (anti-CD20 monoclonal antibody) in lymphoproliferative malignancies: Tata Memorial experience.
    Biswas G; Parikh PM; Nair R; Bhagwat R; Bakshi A; Prabhash K; Vora A; Gupta S; Pai VR; Menon H; Sastry PS
    J Assoc Physicians India; 2006 Jan; 54():29-33. PubMed ID: 16649735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index.
    Vose JM; Bierman PJ; Loberiza FR; Lynch JC; Bociek GR; Weisenburger DD; Armitage JO
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):36-42. PubMed ID: 18158959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of non-Hodgkin's lymphoma-associated pemphigus foliaceus and use of rituximab for treatment.
    Prodanovic EM; Korman NJ
    J Dermatolog Treat; 2008; 19(6):1-3. PubMed ID: 18720187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.